��������

Thomas King currently serves as a member of the Board of Directors at TFF Pharmaceuticals, Inc. and has held various leadership roles, including Chair of the Board at Kinaset Therapeutics, where efforts focus on developing novel respiratory therapeutics for severe asthma. King also acts as Executive Chair at Concentric Analgesics, Inc., which is dedicated to non-opioid pain management solutions, and Achieve Life Sciences, a specialty company targeting nicotine addiction. Previously, King has contributed as Independent Lead Director at Berkshire Biomedical, Senior Advisor at Satsuma Pharmaceuticals, and has held multiple positions at VIVUS, Inc. and Faraday Pharmaceuticals. With an academic background in finance and chemistry from the University of Kansas and McPherson College, King's extensive experience spans over various biotech sectors aimed at improving health outcomes.